Optimizing platelet transfusion therapy.

Abstract:

:Platelet transfusions are widely used. Prophylactic transfusions are employed in severely thrombocytopenic patients without evidence of bleeding, but no randomized trial data prove the safety or efficacy of this approach. Randomized trials have demonstrated the equivalence of transfusion triggers of 10,000 and 20,000/microl for prophylactic transfusions. The former threshold is potentially safer for the patient, conservative of donor resources and leads to lower costs, with perhaps a slightly greater risk of minor hemorrhage. Randomized trials have demonstrated the equivalence of pheresis or whole blood-derived platelet transfusions. The former present a lower risk for infectious agents, and the latter are less expensive and a more efficient use of limited donor resources. Randomized trials prove that leukoreduced and ABO identical platelet transfusions reduce the risks of HLA alloimmunization and platelet transfusion refractoriness (both leukoreduction and ABO matching), transfusion reactions (leukoreduction) and CMV transmission (leukoreduction). Leukoreduction and ABO matching of platelet transfusions also have been associated in preliminary observational studies with reduced morbidity and mortality in surgical patients and reduced infections in patients with leukemia. These results require further investigation. Future challenges include (1) determining the best approach to bacterial contamination of platelets, whether by detection methods or pathogen inactivation and (2) determining the threshold for prophylactic platelet transfusions in thrombocytopenic patients undergoing surgery or invasive procedures.

journal_name

Blood Rev

journal_title

Blood reviews

authors

Heal JM,Blumberg N

doi

10.1016/S0268-960X(03)00057-2

subject

Has Abstract

pub_date

2004-09-01 00:00:00

pages

149-65

issue

3

eissn

0268-960X

issn

1532-1681

pii

S0268960X03000572

journal_volume

18

pub_type

杂志文章,评审
  • Systematic review of staging bone marrow involvement in B cell lymphoma by flow cytometry.

    abstract::The clinical relevance of flow cytometry (FC)-based bone marrow involvement (BMI) in B cell non-Hodgkin lymphoma (B-NHL) is not well established. We conducted a systematic review of MEDLINE regarding the use of FC to establish BMI in B-NHL to determine the prevalence of BMI by FC, to understand the interrelation betwe...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100778

    authors: Sorigue M,Cañamero E,Miljkovic MD

    更新日期:2020-11-08 00:00:00

  • Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding.

    abstract::Stimulation with the vasopressin analogue desmopressin (DDAVP) of extrarenal arginine vasopressin (AVP) V2-receptors in endothelial cells and possible in platelets increases the circulating levels of coagulation factor VIII (FVIII), von Willebrand factor (VWF) and tissue plasminogen activator (t-PA). The purpose of th...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2014.03.001

    authors: Svensson PJ,Bergqvist PB,Juul KV,Berntorp E

    更新日期:2014-05-01 00:00:00

  • Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings.

    abstract::Platelets play a major role in primary hemostasis and thrombus formation. After vascular injury, platelets adhere to injured site and rapidly change their shape that switches the resting platelets to active state. Activated platelets aggregate and secrete biologically active intermediate substances that further potent...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2019.05.007

    authors: Kannan M,Ahmad F,Saxena R

    更新日期:2019-09-01 00:00:00

  • Idiopathic myelofibrosis: historical review, diagnosis and management.

    abstract::Idiopathic myelofibrosis is reviewed from several aspects. The historical development of knowledge about this disorder is discussed, from early descriptions of extramedullary hematopoiesis associated with numerous etiologies, a debate over pathogenetic mechanisms, followed by newer evidence which placed this disorder ...

    journal_title:Blood reviews

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/0268-960x(91)90041-a

    authors: Weinstein IM

    更新日期:1991-06-01 00:00:00

  • What can we learn from ineffective erythropoiesis in thalassemia?

    abstract::Erythropoiesis is a dynamic process regulated at multiple levels to balance proliferation, differentiation and survival of erythroid progenitors. Ineffective erythropoiesis is a key feature of various diseases, including β-thalassemia. The pathogenic mechanisms leading to ineffective erythropoiesis are complex and sti...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2017.10.001

    authors: Oikonomidou PR,Rivella S

    更新日期:2018-03-01 00:00:00

  • Thrombopoietic agents.

    abstract::Thrombopoietin (TPO) is the key cytokine involved in thrombopoiesis, and is the endogenous ligand for the thrombopoietin receptor that is expressed on the surface of platelets, megakaryocytes, and megakaryocytic precursors. First-generation thrombopoietic agents were recombinant forms of human TPO, and their developme...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2010.04.002

    authors: Stasi R,Bosworth J,Rhodes E,Shannon MS,Willis F,Gordon-Smith EC

    更新日期:2010-07-01 00:00:00

  • Molecular diagnosis of haematological neoplasms.

    abstract::DNA analysis has become of practical value in the diagnosis and classification of leukaemias and lymphomas. This is exemplified by the study of lymphoproliferative disorders using immunoglobulin and T-cell receptor gene probes for the determination of clonality and cell lineage. Chromosomal analysis with DNA probes is...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90028-8

    authors: Fey MF,Wainscoat JS

    更新日期:1988-06-01 00:00:00

  • MicroRNAs in hematological malignancies.

    abstract::MicroRNAs (miRNAs) have become one of the hottest topics in biology over recent years, but remarkably have only been formally recognized for just over 10 years. These endogenously produced short (19-24 nt) non-coding RNAs have introduced an entirely new paradigm in our understanding of gene control and it is now evide...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2013.04.002

    authors: Lawrie CH

    更新日期:2013-05-01 00:00:00

  • Iron toxicity - Its effect on the bone marrow.

    abstract::Excess iron can be extremely toxic for the body and may cause organ damage in the absence of iron chelation therapy. Preclinical studies on the role of free iron on bone marrow function have shown that iron toxicity leads to the accumulation of reactive oxygen species, affects the expression of genes coding for protei...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2018.04.004

    authors: Isidori A,Borin L,Elli E,Latagliata R,Martino B,Palumbo G,Pilo F,Loscocco F,Visani G,Cianciulli P

    更新日期:2018-11-01 00:00:00

  • Resuscitation and transfusion principles for traumatic hemorrhagic shock.

    abstract::The transfusion approach to massive hemorrhage has continually evolved since it began in the early 1900s. It started with fresh whole blood and currently consists of virtually exclusive use of component and crystalloid therapy. Recent US military experience has reinvigorated the debate on what the most optimal transfu...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2009.07.003

    authors: Spinella PC,Holcomb JB

    更新日期:2009-11-01 00:00:00

  • Management of venous thromboembolism in athletes.

    abstract::Venous thromboembolism (VTE) is a common condition with high associated morbidity and mortality. Athletes have unique VTE risk factors compared with the general population, and may have a higher than anticipated risk of thrombosis. Anticoagulant treatment poses additional challenges in athletes, as these individuals u...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100780

    authors: Swan D,Carter-Brzezinski L,Thachil J

    更新日期:2020-11-15 00:00:00

  • Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.

    abstract::Parenteral arsenic trioxide (ATO) has been firmly established as a standard therapy for acute promyelocytic leukemia (APL). Despite widespread use of oral arsenicals in medicine historically, they had disappeared from modern pharmacopeia until oral ATO was redeveloped in Hong Kong in 2000. Since then, over 200 patient...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2015.11.004

    authors: Torka P,Al Ustwani O,Wetzler M,Wang ES,Griffiths EA

    更新日期:2016-05-01 00:00:00

  • Congenital platelet disorders.

    abstract::Congenital platelet disorders include thrombocytopathies and thrombocytopenias, which often occur in association. Thrombocytopathies constitute a model for exploring platelet physiology at the molecular level: adhesion, activation, release phenomena, aggregation. Further advances in understanding thrombocytopenias now...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90004-5

    authors: Bellucci S,Caen JP

    更新日期:1988-03-01 00:00:00

  • Antithrombin III deficiency.

    abstract::A moderate reduction of plasma antithrombin activity is an uncommon but clinically important cause of severe thromboembolic disease. In recent years the molecule responsible for the major part of this activity (antithrombin III) has been extensively characterised and the mode of inheritance of familial deficiencies wo...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90013-6

    authors: Beresford CH

    更新日期:1988-12-01 00:00:00

  • Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues.

    abstract::Long-term survival rates in childhood acute lymphoblastic leukemia (ALL) are currently above 85% due to huge improvements in treatment. However, 15-20% of children still experience relapses. Relapses can either occur in the bone marrow or at extramedullary sites, such as gonads or the central nervous system (CNS), for...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2019.04.003

    authors: Gaudichon J,Jakobczyk H,Debaize L,Cousin E,Galibert MD,Troadec MB,Gandemer V

    更新日期:2019-07-01 00:00:00

  • Targeting platelet receptor function in thrombus formation: the risk of bleeding.

    abstract::In this review, we presume that the process of thrombus formation, as assessed in whole blood flow studies and in experimental (murine) thrombosis studies, reflects the platelet responses in human haemostasis and thrombosis. Following this concept, we give an up-to-date overview of the main platelet receptors and sign...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2013.12.001

    authors: Swieringa F,Kuijpers MJ,Heemskerk JW,van der Meijden PE

    更新日期:2014-01-01 00:00:00

  • Treatment of the neutropenia of Felty syndrome.

    abstract::This review sets out to synthesize and critically evaluate the current reported data regarding therapeutic options for the neutropenia associated with Felty syndrome (Felty neutropenia). A MEDLINE search and bibliographies from recent reviews were used to identify trials and case reports that provided sufficient data ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(96)90024-7

    authors: Rashba EJ,Rowe JM,Packman CH

    更新日期:1996-09-01 00:00:00

  • Metabolic regulation of the bone marrow microenvironment in leukemia.

    abstract::Most leukemia patients experience little benefit from immunotherapy, in part due to the immunosuppressive bone marrow microenvironment. Various metabolic mechanisms orchestrate the behaviors of immune cells and leukemia cells in the bone marrow microenvironment. Furthermore, leukemia cells regulate the bone marrow mic...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100786

    authors: Xu B,Hu R,Liang Z,Chen T,Chen J,Hu Y,Jiang Y,Li Y

    更新日期:2020-12-09 00:00:00

  • Treatment of early stage Hodgkin's disease.

    abstract::Current trends in the treatment of patients with Stages I and II Hodgkin's disease are discussed in this review. Recommendations for staging procedures and the updated staging classification are described. Long-term results with extended field radiation therapy overall and in subgroups of patients are detailed. As fol...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(93)90022-v

    authors: Straus DJ

    更新日期:1993-03-01 00:00:00

  • DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.

    abstract::Reactivation of fetal hemoglobin (HbF) expression is an important therapeutic option in patients with hemoglobin disorders. In sickle cell disease (SCD), an increase in HbF would interfere with the polymerization of sickle hemoglobin while in beta-thalassemia, an increase in gamma-globin chain synthesis would decrease...

    journal_title:Blood reviews

    pub_type: 杂志文章

    doi:10.1016/j.blre.2006.01.002

    authors: Fathallah H,Atweh GF

    更新日期:2006-07-01 00:00:00

  • The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy.

    abstract::The finding that T cell immune responses could be divided into those promoting cell mediated immunity (Th1) and humoral responses (Th2) has had a profound effect on the understanding of immune response generation over the last 15 years. With ever increasing knowledge of the immune system, the model has come under crit...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1054/blre.2000.0136

    authors: Lappin MB,Campbell JD

    更新日期:2000-12-01 00:00:00

  • Human retroviruses.

    abstract::After many unsuccessful years of searching, the first pathogenic human retrovirus, the human T-cell leukaemia lymphoma virus (HTLV-I), was reported as recently as 1980 and since that time has been causally linked to the adult T-cell leukaemia lymphoma syndrome. A second HTLV (HTLV-II) isolated shortly afterwards is le...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90010-0

    authors: Thomson BJ,Dalgleish AG

    更新日期:1988-12-01 00:00:00

  • Biochemistry of factor X.

    abstract::Factor X circulates as a serine protease which is converted to the active form at the point of convergence of the intrinsic and extrinsic coagulation pathways. Subsequently, the enzymatic species, factor Xa, is involved in macromolecular complex formation with its cofactor factor Va, a phospholipid surface and calcium...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(94)90007-8

    authors: Hertzberg M

    更新日期:1994-03-01 00:00:00

  • Treatment of newly diagnosed advanced stage Hodgkin lymphoma.

    abstract::ABVD continues to be the standard of care for patients with advanced stage Hodgkin Lymphoma (HL) although escalated BEACOPP has improved survival in one randomized controlled trial (RCT). More intensive regimens have higher rates of acute and late toxicities and this poses significant issues for patients. Consolidatio...

    journal_title:Blood reviews

    pub_type: 杂志文章,随机对照试验,评审

    doi:10.1016/j.blre.2012.04.001

    authors: Uhm J,Kuruvilla J

    更新日期:2012-07-01 00:00:00

  • Disorders of neutrophil function.

    abstract::Major bacterial infections are most commonly associated with agranulocytosis or an abnormality of immunoglobulins or complement. Occasionally, repeated infections cannot be attributed to these relatively common causes. In such cases, a quantitative abnormality in neutrophil function should be sought. Complete evaluati...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(95)90024-1

    authors: Bogomolski-Yahalom V,Matzner Y

    更新日期:1995-09-01 00:00:00

  • Amyloidosis.

    abstract::Amyloidosis is the generic term for a heterogeneous group of disorders characterised by the common finding of amyloid deposition. The various acquired and hereditary syndromes are classified according to the identity of the respective amyloid fibril sub-unit protein. Systemic amyloidosis and some local forms are progr...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(95)90032-2

    authors: Hawkins PN

    更新日期:1995-06-01 00:00:00

  • Results of programmes for antenatal detection of thalassemia in reducing the incidence of the disorder.

    abstract::The characteristics and the effectiveness of programmes designed to prevent beta-thalassemia major present in high frequency in several areas of the world such as Cyprus, Greece and Sardinia are reviewed. All these programmes are based on heterozygote detection, counselling and foetal diagnosis. The target population ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(87)90032-4

    authors: Cao A

    更新日期:1987-09-01 00:00:00

  • A logical approach to the investigation of red cell enzymopathies.

    abstract::This relatively rare group of disorders may cause quite marked morbidity and occasionally be life-threatening. As their inheritance is largely known accurate information in one family member has obvious benefits to other family members as well as the patient. The identification of the defect is dependent on an accurat...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(90)90042-q

    authors: Lestas AN,Bellingham AJ

    更新日期:1990-09-01 00:00:00

  • The role of unrelated bone-marrow transplantation in childhood acute leukaemia.

    abstract::Early reports would suggest that closely matched UD BMT is an adequate substitute for MSD BMT in children with relapsed ALL. Protagonists of BMT might suggest that UD BMT be used in the absence of a MSD in all cases of BM relapse of ALL. However, recent improvements in chemoradiotherapy schedules have reduced the bene...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(96)90006-5

    authors: Veys P

    更新日期:1996-12-01 00:00:00

  • Autologous and allogeneic stem cell transplantation for myelodysplastic syndrome.

    abstract::Allogeneic stem cell transplantation (alloSCT) is the treatment of choice in the majority of young patients with advanced stages MDS if they have a suitable donor. Since outcome of transplantation is superior for patients with a low blast percentage, this supports the use of chemotherapy prior to transplantation in pa...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2006.03.002

    authors: de Witte T,Oosterveld M,Muus P

    更新日期:2007-01-01 00:00:00